Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.1 EUR | 0.00% | +10.87% | -38.92% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 383M 407M | Sales 2022 | 197M 209M | Capitalization | 141M 150M |
---|---|---|---|---|---|
Net income 2021 | 104M 111M | Net income 2022 | 15M 15.98M | EV / Sales 2021 | 0.5 x |
Net cash position 2021 | 96.72M 103M | Net cash position 2022 | 35.09M 37.38M | EV / Sales 2022 | 0.54 x |
P/E ratio 2021 |
2.63
x | P/E ratio 2022 |
9.08
x | Employees | 551 |
Yield 2021 |
7.6% | Yield 2022 |
-
| Free-Float | 39.43% |
1 week | +10.87% | ||
Current month | +5.92% | ||
1 month | +8.51% | ||
3 months | -40.84% | ||
6 months | -40.49% | ||
Current year | -38.92% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Paper
FOU | Founder | 60 | 05-03-14 |
Thomas Lamy
FOU | Founder | - | 05-03-14 |
Larry Abensur
CEO | Chief Executive Officer | 69 | 05-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.1 | 0.00% | 5,290 |
24-04-18 | 5.1 | -2.30% | 11,754 |
24-04-17 | 5.22 | +13.48% | 57,237 |
24-04-16 | 4.6 | 0.00% | 2,802 |
24-04-15 | 4.6 | 0.00% | 4,090 |
Real-time Euronext Paris, April 19, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-38.92% | 58.52M | |
-1.04% | 12.47B | |
-17.29% | 6.99B | |
-2.21% | 5.1B | |
+2.92% | 4.27B | |
-4.79% | 4.27B | |
-50.07% | 3.45B | |
+7.65% | 2.61B | |
-15.92% | 2.08B | |
-3.34% | 1.67B |
- Stock Market
- Equities
- ALBIO Stock